🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Breelyn A. Wilky

ORCID: 0000-0001-5080-497X
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma”.

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0974
N/A
1.3DataRank · unranked
44 citations

Sant P. Chawla, Anthony P. Conley, Breelyn A. Wilky, Anthony W. Tolcher, Nehal J. Lakhani +14 more

Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway

Cancer Research(2023)10.1158/0008-5472.can-22-3173
N/A
0.532DataRank · unranked
15 citations

Matthew D. Galbraith, Neetha Paul Eduthan, Amanda A. Hill, Michael R. Clay, Cristiam Moreno Tellez +5 more

DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors

Journal of Clinical Investigation(2024)10.1172/jci180278
N/A
0.509DataRank · unranked
11 citations

Gabriella Albert, Amelia Sánchez, Jiangli Chen, Jianjun Liu, Andres S. Davalos +11 more

Data from Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

(2023)10.1158/1078-0432.c.6727617.v1
N/A
0DataRank · unranked
0 citations

Sant P. Chawla, Anthony P. Conley, Breelyn A. Wilky, Anthony W. Tolcher, Nehal J. Lakhani +14 more

Data from Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

(2023)10.1158/1078-0432.c.6727617.v2
N/A
0DataRank · unranked
0 citations

Sant P. Chawla, Anthony P. Conley, Breelyn A. Wilky, Anthony W. Tolcher, Nehal J. Lakhani +14 more

RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma

iScience(2024)10.1016/j.isci.2024.108925
N/A
0DataRank · unranked
10 citations

Marwa M. Afifi, Aparna Gorthi, Rachel Weil, Breelyn A. Wilky, Joshua T. Weinreb +7 more

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

Frontiers in Oncology(2025)10.3389/fonc.2025.1546500
N/A
0DataRank · unranked
0 citations

Sama L. Kareem, Bradley R. Corr, Christopher H. Lieu, Breelyn A. Wilky, S. Lindsey Davis +9 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618
N/A
0DataRank · unranked
229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

Immune profiling of tumor-infiltrating lymphocytes in patients with primary and metastatic soft tissue sarcomas 3352

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1165
N/A
0DataRank · unranked
0 citations

Breelyn A. Wilky, Sumra Chaudhry

Mucosal Ulceration in Gastrointestinal Stromal Tumor is an Independent Predictor of Progression-Free Survival

Journal of Surgical Research(2022)10.1016/j.jss.2022.11.076
N/A
0DataRank · unranked
2 citations

Michael R. Bronsert, Breelyn A. Wilky, Martin D. McCarter, Brian Carter

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007440
N/A
0DataRank · unranked
14 citations

Charalampos S. Floudas, Asaf Maoz, Abdul Rafeh Naqash, Carter Norton, Aik Choon Tan +12 more